Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: A double-blind, placebo-controlled study

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Jonkers, René E ^a   Bantje, Theo A ^b   Aalbers, René ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c MARTINI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; METHACHOLINE; PLACEBO; SALBUTAMOL; BRONCHOCONSTRICTING AGENT; BRONCHODILATING AGENT; BUDESONIDE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FORMOTEROL; METHACHOLINE CHLORIDE;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HEART PALPITATION; HUMAN; INHALATION TEST; MALE; METERED DOSE INHALER; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ADOLESCENT; BRONCHOCONSTRICTION; DIAGNOSTIC USE; DRUG COMBINATION; DRUG EFFECTS; MIDDLE AGED; PLACEBO EFFECT;

ADOLESCENT; ADULT; ALBUTEROL; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; BUDESONIDE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DYSPNEA; ETHANOLAMINES; FEMALE; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; PLACEBO EFFECT; TREATMENT OUTCOME;

EID: 33947369481     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-141     Document Type: Article

References (29)

1. van Noord JA, Smeets JJ, Maesen FP: A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction. Respir Med 1998, 92:1346-1351.
2. Politiek MJ, Boorsma M, Aalbers R. Comparison of formoterol, salbutamol and salmeterol in methachollne-induced severe bronchoconstriction. Eur Respir J 1999, 13:988-992.
3. Grembiale RD, Pelaia G, Naty S, Vatrella A, Tranfa CM, Marsico SA: Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. Pulm Phormacol Ther 2002, 15:463-466.
4. Seberova E, Andersson A: Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol give by a pMDI. Respir Med 2000, 94:607-611.
5. Boonsawat W, Charoenratanakul S, Pothirat C, Sawanyawisuth K, Seearamroongruang T, Bengtsson T, Brander R, Selroos O: Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir Med 2003, 97:1067-1074.
6. Tattersfield AE, Lofdahl CG, Postma DS, Eivindson A, Schreurs AG, Rasidakis A, Ekstrom T: Comparison of formoterol and terbutaline for as-needed treatment of asthma: A randomised trial. Lancet 2001, 357:257-261.
7. Cheung D, van Klink HC, Aalbers R, OZON study group: Improved lung function and symptom control with formoterol on demand in asthma. Eur Respir J 2006, 27:504-510.
8. Pauwels RA, Sears MR, Campbell M, Villasante C, Huang S, Lindh A, Petermann W, Aubier M, Schwabe G, Bengtsson T, RELIEF Study Investigators: Formoterol as relief mAdication in asthma: a worldwide safety and effectiveness trial. Eur Respir J 2003, 22:787-794.
9. Global Initiative for Asthma: Global strategy for asthma management and prevention - updated 2005. Hamilton: Global Initiative for Asthma 2005.
10. Zetterström O, Buhl R, Mellem H, Hedman J, O'Neill S, Ekström T: Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001, 18:262-268.
11. Buhl R, Creemers JP, Vondra V, Martelli NA, Naya IP, Ekstrom T: Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma. Respir Med 2003, 97:323-330.
12. Lalloo, UG, Malolepszy J, Kozma D, Krofta K, Ankerst J, Johansen B, Thomson NC: Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest 2003, 123:1480-1487.
13. Bateman ED, Bantje TA, Joao Gomes M, Toumbis MG, Huber RM, Naya I, Eliraz A. Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma. Am J Respir Med 2003, 2:275-28 1.
14. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekstrom T, Bateman ED: Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005, 171:129-136.
15. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG: Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: A randomised controlled, double-blind study. The Lancet 2006, 368:744-753.
16. Barnes PJ: A single inhaler for asthma? Am J Respir Crit Care Med 2005, 171:95-96.
17. Gibson PG: Teaching old dAugs new tricks: asthma therapy adjusted by patient perception or noninvasive markers. Eur Respir J 2005, 25:397-399.
18. Rubinfeld AR, Scicchitano R, Hunt A, Thompson PJ, Van Nooten A, Selroos O: Formoterol Turbuhaler as reliever medication in patients with acute asthma. Eur Respir J 2006, 27:735-741.
19. Balanag VM, Yunus F, Yang PC, Jorup C: Efficacy and safety of budesonide/ formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmocol Ther 2006, 19:139-147.
20. Bateman ED, Fairall L, Lombardi DM, English R: Budesonidel/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respir Res 2006, 7:13.
21. Standards for the diagnosis and are of patients with chronic obstructive pulmonary disease COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987, 136:225-244.
22. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ: Guidelines for methacholine and exercise challenge testing- 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. AmJ Respir Crit Care Med 2000, 161:309-329.
23. Wilson RC, Jones PW: A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond) 1989, 76:277-282.
24. Kendrick KR, Baxi SC, Smith RM: Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs 2000, 26:216-222.
25. Quanjer PH, Tarnmeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5-40.
26. van der Woude, Boorsma M, Bergqvist PB, Winter TH, Aalbers R. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstricion. Pulmonary Pharmacology & Therapeutics 2004, 17:89-95.
27. van der Woude HJ, Postma DS, Politiek MJ, Winter TH, Aalbers R. Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction. Respir Med 2004, 98:816-820.
28. Scicchitano R, Aalbers R, Ukena D, Manira A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C: Efficacy and safety of budesonide/ formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004, 20:1403-1418.
29. Vogelmeier C, D'Urzo A, Pauwels R, Merino JM, Jaspal M, Boutet S, Naya I, Price D: Budesonide/formoterol maintenance and reliever therapy. an effective asthma treatment option? Eur Respir J 2005, 26:819-828.